Omada study shows GLP-1 care program boosts weight loss, preserves muscle mass
Share
Listen to the news
Omada study shows GLP-1 care program boosts weight loss, preserves muscle mass
  • Omada Health released results from a 12-week study of its GLP-1 Care Track in adults with obesity who recently started GLP-1 drugs for weight management.
  • Study showed participants using Omada program achieved greater weight loss than a control group without access to Omada.
  • Results also indicated improved body composition, with more fat loss and better muscle preservation versus controls, addressing a key concern around GLP-1-related lean mass loss.
  • Participants in Omada program reported stronger gains in mental health, physical functioning, and confidence to sustain weight loss than comparison participants.
  • Findings support Omada strategy to position its GLP-1 companion offering as a higher-value benefit for employers and health plans by emphasizing quality of weight loss, not only total pounds lost.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omada Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604170900PRIMZONEFULLFEED9691842) on April 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending